FAST Spring 2020 Showcase a Virtual Success!
Six startups presented to over 125 people during a dynamic FAST Spring 2020 virtual Showcase in late June. The five companies included: ARIZ Precision Medicine, developing potentially curative therapeutics that selectively deliver fatal genetic messages to cancer cells while at the same time sparing healthy cells; Argonaut Genomics, developing novel cancer antigens for immunotherapies including therapeutic cancer vaccines and cell therapies; Immulus – developing GMP manufacturing process for platform technology for use in T cell therapy biomanufacturer; Membio, developing a safe and sustainable blood supply through its patented production of fully functional red blood cells; NeuScience, developing transformative phenotypic screens to target solid tumor cancers, and; Respira Labs, working on improving Chronic Obstructive Pulmonary Disease (COPD) care through a smartphone-based attack-detection platform that can quantitatively measure lung function deterioration using smart acoustics and Machine Learning.
The FAST advisory program provides select entrepreneurs with intensive team review and coaching to perfect their business model, product development plans, and to build a compelling commercialization strategy. To date, 73 FAST Companies have raised >$1.25B, and have achieved 27 Series A or greater investments, 6 successful Exits, and 17 Strategic Partnerships; and have created 450 new jobs.
The FAST Fall Review Session to select companies for the FAST Fall 2020 program took place on July 27-28. Our thanks to AbbVie, Alexandria Real Estate, Bayer, Gilead, Morrison Foerster, Roche and Ximedica for supporting the FAST program!